CTSZ and myeloid sarcoma: One of these gene regions, CTSZ, was previously reported to be hypomethylated in MS in post-mortem brain tissue (Huynh et al., 2014) and to also be associated with risk of systemic sclerosis (Zhu et al., 2018).